Engineered Bacteria Target Cancer Cells | Concord News

Scientists have engineered E. coli to produce a targeted compound that flags cancer cells for immune destruction—offering a revolutionary, minimally invasive cancer treatment. This breakthrough, built on synthetic biology, could reshape oncology, though rigorous human trials are still needed to confirm safety and efficacy. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ea905791dfe16c38